Healthcare Infection Control Practices Advisory Committee; Correction, 88281-88282 [2024-25906]

Download as PDF Federal Register / Vol. 89, No. 216 / Thursday, November 7, 2024 / Notices Estimated Time per Response: 0.017 hours–52 hours. Obligation To Respond: Required to obtain or retain benefits. The statutory authority for this collection of information is contained in Sections 154(i), 307, 308, 309 and 319 of the Communications Act of 1934, as amended. Total Annual Burden: 172,087 hours. Total Annual Cost: $1,851,000. Needs and Uses: On November 29, 1999, the Community Broadcasters Protection Act of 1999 (CBPA), Public Law 106–113, 113 Stat. appendix I at pp. 1501A–594–1501A–598 (1999), codified at 47 U.S.C. 336(f), was enacted. That legislation provided that a low power television (LPTV) licensee should be permitted to convert the secondary status of its station to the new Class A status, provided it can satisfy certain statutorily-established criteria by January 28, 2000. The CBPA directs that Class A licensees be subject to the same license terms and renewal standards as full-power television licenses and that Class A licensees be accorded primary status as television broadcasters as long as they continue to meet the requirements set forth in the statute for a qualifying low power station. For those stations that met the certification deadline, the CBPA sets out certain certification procedures, prescribes the criteria to maintain a Class A license, and outlines the interference protection Class A stations must provide to analog, digital, LPTV and TV translator stations. The CBPA directs that Class A stations must comply with the operating requirements for full-service television broadcast stations in order to maintain Class A status. Therefore, beginning on the date of its application for a Class A license and thereafter, a station must be ‘‘in compliance’’ with the Commission’s operating rules for full-service television stations, contained in 47 CFR part 73. Federal Communications Commission. Marlene Dortch, Secretary, Office of the Secretary. BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION lotter on DSK11XQN23PROD with NOTICES1 Sunshine Act Meetings Wednesday, November 13, 2024, at 10:00 a.m. and its continuation at the conclusion of the open meeting on November 14, 2024. PLACE: 1050 First Street NE, Washington, DC, and virtual (This meeting will be a hybrid meeting.) VerDate Sep<11>2014 18:15 Nov 06, 2024 Jkt 265001 (Authority: Government in the Sunshine Act, 5 U.S.C. 552b) Vicktoria J. Allen, Deputy Secretary of the Commission. [FR Doc. 2024–25999 Filed 11–5–24; 4:15 pm] BILLING CODE 6715–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee; Correction Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice; correction. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). The meeting is open to the public. SUMMARY: FOR FURTHER INFORMATION CONTACT: [FR Doc. 2024–25895 Filed 11–6–24; 8:45 am] TIME AND DATE: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. 30109. Matters relating to internal personnel decisions, or internal rules and practices. Information the premature disclosure of which would be likely to have a considerable adverse effect on the implementation of a proposed Commission action. Matters concerning participation in civil actions or proceedings or arbitration. CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. STATUS: Sydnee Byrd, M.P.A., Program Analyst, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027. Telephone: (404) 718– 8039; Email: HICPAC@cdc.gov. SUPPLEMENTARY INFORMATION: Correction Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee; November 14, 2024, from 9 a.m. to 5 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 88281 p.m., EST, and November 15, 2024, from 9 a.m. to 12 p.m., EST, in the original Federal Register notice. Notice of the virtual meeting was published in the Federal Register on October 17, 2024, 89 FR 83688. The meeting notice is being amended to update the dates section; addresses section; and supplementary information section, including the addition of instructions for providing written public comment. These sections should read as follows: DATES: The meeting will be held on November 14, 2024, from 8 a.m. to 5:45 p.m., EST, and November 15, 2024, from 8 a.m. to 12:30 p.m., EST. ADDRESSES: The meeting will be webcast live via the World Wide Web. The webcast link can be found on the HICPAC website at https:// www.cdc.gov/hicpac/php/upcomingmeeting/. SUPPLEMENTARY INFORMATION: Purpose: The Healthcare Infection Control Practices Advisory Committee (HICPAC) is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion; the Director, National Center for Emerging and Zoonotic Infectious Diseases; the Director, Centers for Disease Control and Prevention (CDC); and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Considered: The agenda will include the following updates: the Division of Healthcare Quality Promotion; the Isolation Precautions Guideline Workgroup; and the Healthcare Personnel Guideline Workgroup. Agenda items are subject to change as priorities dictate. Public Participation Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. All persons interested in making an oral public comment at the November 14–15, 2024, HICPAC meeting must submit a request between October 15, 2024, and October 25, 2024, at https:// www.cdc.gov/hicpac/php/upcoming- E:\FR\FM\07NON1.SGM 07NON1 88282 Federal Register / Vol. 89, No. 216 / Thursday, November 7, 2024 / Notices meeting/ no later than 5 p.m., EDT, on October 25, 2024, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a random draw to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by November 1, 2024. Written Public Comment: Written comments should be submitted by email to HICPAC@cdc.gov. The deadline for receipt of written public comments is November 22, 2024. All submissions must contain the submitter’s name, address, and organizational affiliation, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length, not including attachments. All written comments will be shared with the Committee. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–25906 Filed 11–6–24; 8:45 am] ACTION: Notice This quarterly notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published in the 3-month period, relating to the Medicare and Medicaid programs and other programs administered by CMS. SUMMARY: It is possible that an interested party may need specific information and not be able to determine from the listed information whether the issuance or regulation would fulfill that need. Consequently, we are providing contact persons to answer general questions concerning each of the addenda published in this notice. FOR FURTHER INFORMATION CONTACT: BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–9150–N] Medicare and Medicaid Programs; Quarterly Listing of Program Issuances—July through September 2024 Centers for Medicare & Medicaid Services (CMS), Health and Human Services (HHS). AGENCY: Addenda Contact I—CMS Manual Instructions ..................................................................................................... II—Regulation Documents Published in the FEDERAL REGISTER ............................................. III—CMS Rulings ...................................................................................................................... IV—Medicare National Coverage Determinations .................................................................... V—FDA-Approved Category B IDEs ........................................................................................ VI—Collections of Information .................................................................................................. VII—Medicare–Approved Carotid Stent Facilities .................................................................... VIII—American College of Cardiology-National Cardiovascular Data Registry Sites .............. IX—Medicare’s Active Coverage-Related Guidance Documents ............................................ X—One-time Notices Regarding National Coverage Provisions ............................................. XI—National Oncologic Positron Emission Tomography Registry Sites ................................. XII—Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities .............. XIII—Medicare-Approved Lung Volume Reduction Surgery Facilities ..................................... XIV—Medicare-Approved Bariatric Surgery Facilities .............................................................. XV—Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials ...................... All Other Information ................................................................................................................. Ismael Torres ......................... Terri Plumb ............................. Tiffany Lafferty ........................ Wanda Belle, MPA ................. John Manlove ......................... William Parham ...................... Sarah Fulton, MHS ................. Sarah Fulton, MHS ................. Lori Ashby, MA ....................... JoAnna Baldwin, MS .............. David Dolan, MBA .................. David Dolan, MBA .................. Sarah Fulton, MHS ................. Sarah Fulton, MHS ................. David Dolan, MBA .................. Annette Brewer ....................... SUPPLEMENTARY INFORMATION: I. Background lotter on DSK11XQN23PROD with NOTICES1 announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The Centers for Medicare & Medicaid Services (CMS) is responsible for administering the Medicare and Medicaid programs and coordination and oversight of private health insurance. Administration and oversight of these programs involves the following: (1) furnishing information to Medicare and Medicaid beneficiaries, health care providers, and the public; and (2) maintaining effective communications with CMS regional offices, state governments, state Medicaid agencies, state survey agencies, various providers of health care, all Medicare contractors that VerDate Sep<11>2014 18:15 Nov 06, 2024 Jkt 265001 process claims and pay bills, National Association of Insurance Commissioners (NAIC), health insurers, and other stakeholders. To implement the various statutes on which the programs are based, we issue regulations under the authority granted to the Secretary of the Department of Health and Human Services under sections 1102, 1871, 1902, and related provisions of the Social Security Act (the Act) and Public Health Service Act. We also issue various manuals, memoranda, and statements necessary to administer and oversee the programs efficiently. Section 1871(c) of the Act requires that we publish a list of all Medicare manual instructions, interpretive rules, statements of policy, and guidelines of PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Phone number (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) (410) 786–1864 786–4481 786–7548 786–7491 786–6877 786–4669 786–2749 786–2749 786–6322 786–7205 786–3365 786–3365 786–2749 786–2749 786–3365 786–6580 general applicability not issued as regulations at least every 3 months in the Federal Register. II. Format for the Quarterly Issuance Notices This quarterly notice provides only the specific updates that have occurred in the 3-month period along with a hyperlink to the full listing that is available on the CMS website or the appropriate data registries that are used as our resources. This is the most current up-to-date information and will be available earlier than we publish our quarterly notice. We believe the website list provides more timely access for beneficiaries, providers, and suppliers. We also believe the website offers a E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 89, Number 216 (Thursday, November 7, 2024)]
[Notices]
[Pages 88281-88282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25906]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee; 
Correction

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces an amendment 
to the following meeting of the Healthcare Infection Control Practices 
Advisory Committee (HICPAC). The meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst, 
Division of Healthcare Quality Promotion, National Center for Emerging 
and Zoonotic Infectious Diseases, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 
30329-4027. Telephone: (404) 718-8039; Email: [email protected].

SUPPLEMENTARY INFORMATION:

Correction

    Notice is hereby given of a change in the meeting of the Healthcare 
Infection Control Practices Advisory Committee; November 14, 2024, from 
9 a.m. to 5 p.m., EST, and November 15, 2024, from 9 a.m. to 12 p.m., 
EST, in the original Federal Register notice.
    Notice of the virtual meeting was published in the Federal Register 
on October 17, 2024, 89 FR 83688.
    The meeting notice is being amended to update the dates section; 
addresses section; and supplementary information section, including the 
addition of instructions for providing written public comment. These 
sections should read as follows:

DATES: The meeting will be held on November 14, 2024, from 8 a.m. to 
5:45 p.m., EST, and November 15, 2024, from 8 a.m. to 12:30 p.m., EST.

ADDRESSES: The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the HICPAC website at https://www.cdc.gov/hicpac/php/upcoming-meeting/.

SUPPLEMENTARY INFORMATION:
    Purpose: The Healthcare Infection Control Practices Advisory 
Committee (HICPAC) is charged with providing advice and guidance to the 
Director, Division of Healthcare Quality Promotion; the Director, 
National Center for Emerging and Zoonotic Infectious Diseases; the 
Director, Centers for Disease Control and Prevention (CDC); and the 
Secretary, Department of Health and Human Services, regarding (1) the 
practice of healthcare infection prevention and control; (2) strategies 
for surveillance, prevention, and control of infections, antimicrobial 
resistance, and related events in settings where healthcare is 
provided; and (3) periodic updating of CDC guidelines and other policy 
statements regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters to be Considered: The agenda will include the following 
updates: the Division of Healthcare Quality Promotion; the Isolation 
Precautions Guideline Workgroup; and the Healthcare Personnel Guideline 
Workgroup. Agenda items are subject to change as priorities dictate.

Public Participation

    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Priority will be given to 
individuals who submit a request to make an oral public comment before 
the meeting according to the procedures below. All persons interested 
in making an oral public comment at the November 14-15, 2024, HICPAC 
meeting must submit a request between October 15, 2024, and October 25, 
2024, at https://www.cdc.gov/hicpac/php/upcoming-

[[Page 88282]]

meeting/ no later than 5 p.m., EDT, on October 25, 2024, 
according to the instructions provided. If the number of persons 
requesting to speak is greater than can be reasonably accommodated 
during the scheduled time, CDC will conduct a random draw to determine 
the speakers for the scheduled public comment session. CDC staff will 
notify individuals regarding their request to speak by email by 
November 1, 2024.
    Written Public Comment: Written comments should be submitted by 
email to [email protected]. The deadline for receipt of written public 
comments is November 22, 2024. All submissions must contain the 
submitter's name, address, and organizational affiliation, as well as 
the topic being addressed. Written comments should not exceed one 
single-spaced typed page in length, not including attachments. All 
written comments will be shared with the Committee.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-25906 Filed 11-6-24; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.